CAM
NYMX

Cubic Asset Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Cubic Asset Management’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4K Hold
10,000
– – ﹤0.01% 200
2023
Q4 		$5.9K Hold
10,000
– – ﹤0.01% 202
2023
Q3 		$5.25K Hold
10,000
– – ﹤0.01% 199
2023
Q2 		$1.9K Hold
10,000
– – ﹤0.01% 199
2023
Q1 		$3.4K Sell
10,000
-4,000
-29% -$1.63K ﹤0.01% 194
2022
Q4 		$4.53K Hold
14,000
– – ﹤0.01% 194
2022
Q3 		$6K Hold
14,000
– – ﹤0.01% 192
2022
Q2 		$6K Hold
14,000
– – ﹤0.01% 193
2022
Q1 		$18K Hold
14,000
– – ﹤0.01% 195
2021
Q4 		$18K Buy
14,000
+900
+7% +$1.44K ﹤0.01% 203
2021
Q3 		$27K Buy
13,100
+250
+2% +$443 0.01% 186
2021
Q2 		$20K Buy
12,850
+1,350
+12% +$2.5K ﹤0.01% 184
2021
Q1 		$26K Buy
11,500
+250
+2% +$659 0.01% 178
2020
Q4 		$28K Buy
11,250
+750
+7% +$1.66K 0.01% 168
2020
Q3 		$26K Buy
+10,500
New +$30.6K 0.01% 155

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

Cubic Asset Management's NYMX Position: Q1 2024 in Review

Cubic Asset Management held its Nymox Pharmaceutical Corp (NYMX) position steady in Q1 2024 at 10,000 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #200.

Cubic Asset Management first reported a position in NYMX in Q3 2020 and has held it in 15 quarters since. The position peaked at $28K in Q4 2020. 3 funds tracked by Wall St. Rank hold NYMX as of Q1 2024.

  • Cubic Asset Management held 10,000 shares of Nymox Pharmaceutical Corp worth $4K as of Q1 2024.
  • Cubic Asset Management left its Nymox Pharmaceutical Corp share count unchanged in Q1 2024.
  • Nymox Pharmaceutical Corp made up ﹤0.01% of Cubic Asset Management's portfolio in Q1 2024, its #200 holding.
  • Cubic Asset Management first reported a position in Nymox Pharmaceutical Corp in Q3 2020 and has held it in 15 quarters since.
  • Cubic Asset Management's Nymox Pharmaceutical Corp position peaked at $28K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2024.

Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.